Inscription Capital LLC Decreases Position in Ingredion Incorporated $INGR

Inscription Capital LLC reduced its stake in Ingredion Incorporated (NYSE:INGR) by 66.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,347 shares of the company’s stock after selling 4,626 shares during the period. Inscription Capital LLC’s holdings in Ingredion were worth $259,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. WPG Advisers LLC boosted its holdings in shares of Ingredion by 100.8% in the 3rd quarter. WPG Advisers LLC now owns 245 shares of the company’s stock valued at $30,000 after buying an additional 123 shares in the last quarter. Root Financial Partners LLC acquired a new stake in Ingredion during the 3rd quarter worth $36,000. Capital Advisors Ltd. LLC lifted its position in Ingredion by 40.5% in the fourth quarter. Capital Advisors Ltd. LLC now owns 354 shares of the company’s stock valued at $39,000 after acquiring an additional 102 shares during the last quarter. Caitong International Asset Management Co. Ltd boosted its stake in Ingredion by 166.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 381 shares of the company’s stock valued at $47,000 after acquiring an additional 238 shares in the last quarter. Finally, SJS Investment Consulting Inc. boosted its stake in Ingredion by 4,000.0% in the third quarter. SJS Investment Consulting Inc. now owns 410 shares of the company’s stock valued at $50,000 after acquiring an additional 400 shares in the last quarter. Institutional investors and hedge funds own 85.27% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on INGR shares. Stephens reiterated an “equal weight” rating and set a $120.00 target price on shares of Ingredion in a research report on Wednesday, February 4th. Benchmark initiated coverage on Ingredion in a research report on Tuesday, March 17th. They issued a “buy” rating and a $130.00 target price for the company. Barclays raised their price target on Ingredion from $124.00 to $128.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. UBS Group reduced their price objective on Ingredion from $124.00 to $122.00 and set a “neutral” rating for the company in a research note on Thursday, April 9th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Ingredion in a report on Friday, March 27th. Two analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $124.71.

Insider Transactions at Ingredion

In other Ingredion news, SVP Larry Fernandes sold 1,125 shares of the business’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $116.55, for a total value of $131,118.75. Following the transaction, the senior vice president directly owned 30,514 shares of the company’s stock, valued at approximately $3,556,406.70. The trade was a 3.56% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Davida Marie Gable sold 375 shares of the company’s stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $112.44, for a total transaction of $42,165.00. Following the transaction, the vice president owned 7,110 shares of the company’s stock, valued at approximately $799,448.40. The trade was a 5.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 48,686 shares of company stock worth $5,784,010 over the last 90 days. 1.60% of the stock is currently owned by insiders.

Ingredion Price Performance

Shares of NYSE:INGR opened at $111.79 on Thursday. Ingredion Incorporated has a one year low of $102.31 and a one year high of $141.78. The stock has a market capitalization of $7.05 billion, a price-to-earnings ratio of 10.02, a PEG ratio of 0.90 and a beta of 0.70. The company has a 50-day simple moving average of $113.38 and a 200-day simple moving average of $113.29. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.73 and a current ratio of 2.66.

Ingredion (NYSE:INGR) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $2.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.59 by ($0.06). The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.78 billion. Ingredion had a return on equity of 17.32% and a net margin of 10.10%.The business’s quarterly revenue was down 2.4% compared to the same quarter last year. During the same period in the prior year, the business earned $2.63 EPS. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. On average, analysts predict that Ingredion Incorporated will post 11.38 EPS for the current year.

Ingredion Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 21st. Stockholders of record on Wednesday, April 1st were issued a $0.82 dividend. The ex-dividend date of this dividend was Wednesday, April 1st. This represents a $3.28 dividend on an annualized basis and a dividend yield of 2.9%. Ingredion’s payout ratio is presently 29.39%.

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.